by Admin | Jun 9, 2021 | CME INDIA Repository
CME INDIA Presentation by Admin. “COVAT- 2 got preprint version (Not peer-reviewed) published on 4rth of June 2021 and its message spread like a wild fire. The study found good antibody response in 95% of the study participants 21 days after they received the second...
by Admin | Apr 15, 2021 | CME INDIA Repository
CME INDIA Presentation by Admin. Much awaited COVAT study is now online. The COVAT Study will complete by September-October 2021. This is the interim result after first dose of COVISHIELD and COVAXIN. It clearly indicates how both these vaccines behaved in antibody...
by Admin | Apr 13, 2021 | CME INDIA Repository
CME INDIA Presentation by Dr S K Gupta, MBBS MD (Med), CFM (France), Senior Consultant Physician Hosp, Delhi. Migraine and Covid vaccine Headache is a very common side effect of currently approved Covid Vaccines The leaflet insert of Covishield (AstraZeneca Oxford)...
by Admin | Apr 3, 2021 | CME INDIA Repository
CME INDIA Presentation by Dr S K Gupta, MBBS MD(Med), CFM (France), Senior Consultant Physician, Max Hospital, Delhi. Does COVID vaccine cause Antibody Dependent Enhancement? As the second wave is getting momentum, people rush to get vaccinated. Many co-morbidities...
by Admin | Mar 23, 2021 | CME INDIA Repository
CME INDIA Presentation by Admin. If you took after 4 weeks, nothing to worry. Covishield Shines The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at...
